Clinical trial · Interventional
3 Tesla MRI in Patients With Bladder Cancer
Imaging of Bladder Cancer Using Clinical 3 Tesla MRI and EX-VIVO Ultra-High-Field MRI.
NCT00938145CI-TRIAL-00088450active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: New diagnostic procedures, such as 3 Tesla magnetic resonance imaging (MRI), may help find bladder cancer and learn the extent of disease. PURPOSE: This clinical trial is studying how well 3 Tesla MRI works in finding cancer in patients with bladder cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| chemotherapy | Drug | Chemotherapy | ALIAS |
| Cystectomy and Lymphadenectomy | Procedure | — | UNRESOLVED |
| Specimen Ultra-High field MRI | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- MRI+surgery
- description
- 3 Tesla MRI/Cystectomy and Lymphadenectomy/Urinary Diversion/Specimen Ultra-High field MRI
- interventionNames
- Procedure: Specimen Ultra-High field MRI
- Procedure: Cystectomy and Lymphadenectomy
- type
- EXPERIMENTAL
- label
- MRI+surgery+chemotherapy
- description
- 3 Tesla MRI/Cystectomy and Lymphadenectomy/Urinary Diversion/Specimen Ultra-High field MRI/chemotherapy
- interventionNames
- Procedure: Specimen Ultra-High field MRI
- Drug: chemotherapy
- Procedure: Cystectomy and Lymphadenectomy
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Known bladder cancer * Scheduled for radical cystectomy and lymph node dissection. * Able and willing to give valid written informed consent. * No contraindications to the MRI(magnetic resonance imaging). Exclusion Criteria: * Not pregnant, planning to become pregnant during the study, or nursing. * No allergy to contrast agents. * Patient with significant renal insufficiency, i.e. an estimated glomerular filtration rate(eGRF) less than 30 mL/min/1.73m2. * Any condition conflict based on the investigation's clinical judgment that would prevent the patient from completion all trial assessments and visits. * Inability or unwillingness to cooperate with requirements of this trial. * Patients who exhibit noticeable anxiety and/or claustrophobia or who exhibit severe vertigo when they are moved into the MR. * Patients with sickle cell anemia and other hemolytic anemia.
References
Publications (0)
Data not yet available
No reference posted for this study.